Hong Leong Asia Ltd
SGX:H22
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hong Leong Asia Ltd
SGX:H22
|
SG |
|
X
|
Xtant Medical Holdings Inc
AMEX:XTNT
|
US |
|
B
|
Bridge SaaS Ltd
ASX:BGE
|
AU |
|
S
|
Stratos Renewables Corp
OTC:SRNW
|
US |
|
Chain Bridge I
NASDAQ:CBRG
|
US |
|
Naturhouse Health SA
MAD:NTH
|
ES |
Wall Street
Price Targets
H22 Price Targets Summary
Hong Leong Asia Ltd
According to Wall Street analysts, the average 1-year price target for
H22
is 4.08 SGD
with a low forecast of 2.83 SGD and a high forecast of 4.95 SGD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is H22's stock price target?
Price Target
4.08
SGD
According to Wall Street analysts, the average 1-year price target for
H22
is 4.08 SGD
with a low forecast of 2.83 SGD and a high forecast of 4.95 SGD.
What is Hong Leong Asia Ltd's Revenue forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Hong Leong Asia Ltd's revenue is
1%.
The projected
CAGR
for the next 3 years is
9%.
What is Hong Leong Asia Ltd's Operating Income forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Hong Leong Asia Ltd's operating income is
-2%.
The projected
CAGR
for the next 3 years is
10%.
What is Hong Leong Asia Ltd's Net Income forecast?
Projected CAGR
23%
For the last 14 years the
compound annual growth rate for
Hong Leong Asia Ltd's net income is
2%.
The projected
CAGR
for the next 3 years is
23%.
